ETR:MOR - MorphoSys Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: €109.78
  • Forecasted Upside: 45.25 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
€75.58
▼ -1.86 (-2.40%)
1 month | 3 months | 12 months
Get New MorphoSys Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
€109.78
▲ +45.25% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for MorphoSys in the last 3 months. The average price target is €109.78, with a high forecast of €140.00 and a low forecast of €88.00. The average price target represents a 45.25% upside from the last price of €75.58.
Hold
The current consensus among 9 contributing investment analysts is to hold stock in MorphoSys. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/18/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
4/8/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€116.00
i
3/25/2021JPMorgan Chase & Co.Set Price TargetBuy€110.00
i
3/22/2021The Goldman Sachs GroupSet Price TargetNeutral€88.00
i
3/17/2021Independent ResearchSet Price TargetBuy€95.00
i
3/17/2021Berenberg BankSet Price TargetBuy€140.00
i
3/16/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
3/16/2021JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
3/16/2021The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
3/16/2021Royal Bank of CanadaSet Price TargetNeutral€130.00
i
3/3/2021Independent ResearchSet Price TargetBuy€120.00
i
3/3/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
3/2/2021The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
3/2/2021BarclaysSet Price TargetNeutral€90.00
i
2/10/2021BarclaysSet Price TargetNeutral€90.00
i
2/10/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
2/9/2021The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
2/9/2021JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
1/22/2021BarclaysSet Price TargetNeutral€90.00
i
1/18/2021JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
1/8/2021Morgan StanleySet Price TargetNeutral€105.00
i
1/4/2021JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
12/14/2020Berenberg BankSet Price TargetBuy€140.00
i
12/3/2020JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
11/27/2020Independent ResearchSet Price TargetBuy€120.00
i
11/25/2020Morgan StanleySet Price TargetNeutral€105.00
i
11/18/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
11/13/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
11/13/2020Berenberg BankSet Price TargetBuy€140.00
i
11/13/2020BarclaysSet Price TargetNeutral€90.00
i
11/12/2020Royal Bank of CanadaSet Price TargetNeutral€130.00
i
10/28/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
10/14/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
10/5/2020Berenberg BankSet Price TargetBuy€140.00
i
10/5/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
10/2/2020BarclaysSet Price TargetNeutral€110.00
i
9/30/2020JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
9/29/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
9/23/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
8/25/2020Independent ResearchSet Price TargetNeutral€117.00
i
8/17/2020BarclaysSet Price TargetNeutral€105.00
i
8/17/2020The Goldman Sachs GroupSet Price TargetNeutral€110.00
i
8/10/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
8/3/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
8/3/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
8/3/2020Royal Bank of CanadaSet Price TargetNeutral€130.00
i
8/3/2020JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
7/27/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
7/17/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
6/10/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
6/2/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/22/2020JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
5/21/2020Royal Bank of CanadaSet Price TargetBuy€113.00
i
5/14/2020JPMorgan Chase & Co.Set Price TargetBuy€150.00
i
5/14/2020Independent ResearchSet Price TargetBuy€138.00
i
5/13/2020BarclaysSet Price TargetNeutral€105.00
i
5/12/2020HSBCSet Price TargetNeutral€114.00
i
5/8/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/7/2020JPMorgan Chase & Co.Set Price TargetBuy€150.00
i
5/7/2020Royal Bank of CanadaSet Price TargetBuy€113.00
i
4/15/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
4/7/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
3/24/2020BarclaysSet Price TargetNeutral€110.00
i
3/23/2020Berenberg BankSet Price TargetBuy€150.00
i
3/23/2020Independent ResearchSet Price TargetBuy€119.00
i
3/19/2020Royal Bank of CanadaSet Price TargetBuy€130.00
i
3/19/2020JPMorgan Chase & Co.Reiterated RatingBuy
i
3/3/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
2/5/2020Berenberg BankSet Price TargetBuy€150.00
i
2/3/2020BarclaysSet Price TargetNeutral€110.00
i
1/23/2020Berenberg BankSet Price TargetBuy€150.00
i
1/22/2020Independent ResearchSet Price TargetNeutral€130.00
i
1/22/2020The Goldman Sachs GroupReiterated RatingNeutral
i
1/20/2020JPMorgan Chase & Co.Set Price TargetBuy€150.00
i
1/15/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
1/13/2020Berenberg BankSet Price TargetBuy€145.00
i
1/13/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
1/13/2020JPMorgan Chase & Co.Set Price TargetBuy€150.00
i
1/6/2020JPMorgan Chase & Co.Set Price TargetBuy€150.00
i
1/2/2020The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
12/11/2019JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
12/10/2019Royal Bank of CanadaSet Price TargetBuy€130.00
i
12/10/2019Berenberg BankSet Price TargetBuy€145.00
i
12/6/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
12/4/2019Berenberg BankSet Price TargetBuy€145.00
i
11/19/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
11/19/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
11/19/2019Berenberg BankSet Price TargetBuy€145.00
i
11/19/2019Royal Bank of CanadaSet Price TargetBuy€130.00
i
11/18/2019JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
11/11/2019Berenberg BankSet Price TargetBuy€145.00
i
11/7/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
11/7/2019Royal Bank of CanadaSet Price TargetBuy€130.00
i
11/1/2019Independent ResearchSet Price TargetNeutral€110.00
i
11/1/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€129.00
i
10/30/2019JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
10/29/2019Berenberg BankSet Price TargetBuy€150.00
i
10/29/2019Royal Bank of CanadaSet Price TargetBuy€130.00
i
10/29/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
9/26/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
9/24/2019Independent ResearchSet Price TargetNeutral€117.00
i
9/11/2019JPMorgan Chase & Co.Set Price TargetBuy€130.00
i
9/9/2019Berenberg BankSet Price TargetBuy€150.00
i
8/16/2019HSBCSet Price TargetSell€81.00
i
8/13/2019Independent ResearchSet Price TargetNeutral€116.00
i
8/9/2019Royal Bank of CanadaSet Price TargetBuy€130.00
i
8/8/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€133.00
i
8/7/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
8/7/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
8/5/2019Berenberg BankSet Price TargetBuy€150.00
i
7/18/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€133.00
i
7/16/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
7/4/2019Independent ResearchSet Price TargetNeutral€96.00
i
6/26/2019Independent ResearchSet Price TargetNeutral€96.00
i
6/24/2019Royal Bank of CanadaSet Price TargetSell€65.00
i
6/24/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
6/24/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
6/17/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
6/11/2019Berenberg BankSet Price TargetBuy€108.00
i
6/11/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/29/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
5/23/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/21/2019Berenberg BankSet Price TargetBuy€108.00
i
5/17/2019Royal Bank of CanadaSet Price TargetSell€65.00
i
5/17/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
5/17/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/15/2019Berenberg BankSet Price TargetBuy€108.00
i
5/9/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
5/9/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€125.00
i
5/9/2019Independent ResearchSet Price TargetNeutral€96.00
i
5/8/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
4/26/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€125.00
i
4/16/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
4/4/2019JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
4/2/2019Berenberg BankSet Price TargetBuy€108.00
i
3/25/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
3/18/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
3/15/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€125.00
i
3/14/2019Independent ResearchSet Price TargetNeutral€96.00
i
3/14/2019Royal Bank of CanadaSet Price TargetSell€65.00
i
3/11/2019JPMorgan Chase & Co.Reiterated RatingBuy€135.00
i
3/11/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
3/6/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€125.00
i
2/28/2019Berenberg BankSet Price TargetNeutral€108.00
i
2/21/2019Berenberg BankSet Price TargetNeutral€108.00
i
2/15/2019Berenberg BankSet Price TargetNeutral€108.00
i
2/4/2019Royal Bank of CanadaSet Price TargetSell€65.00
i
1/29/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
1/29/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€125.00
i
1/28/2019JPMorgan Chase & Co.Set Price TargetBuy€135.00
i
1/28/2019Royal Bank of CanadaSet Price TargetSell€65.00
i
1/23/2019Deutsche Bank AktiengesellschaftReiterated RatingBuy€125.00
i
1/18/2019The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
1/14/2019JPMorgan Chase & Co.Set Price TargetBuy€135.00
i
1/2/2019JPMorgan Chase & Co.Set Price TargetBuy€135.00
i
12/17/2018The Goldman Sachs GroupSet Price TargetNeutral€114.00
i
12/12/2018JPMorgan Chase & Co.Reiterated RatingBuy
i
12/10/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€130.00
i
12/6/2018JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
12/3/2018Royal Bank of CanadaSet Price TargetSell€65.00
i
11/28/2018Independent ResearchSet Price TargetNeutral€104.00
i
11/26/2018Royal Bank of CanadaSet Price TargetSell€65.00
i
11/19/2018Oddo BhfSet Price TargetBuy€116.00
i
11/16/2018CommerzbankSet Price TargetNeutral€107.00
i
11/13/2018JPMorgan Chase & Co.Set Price TargetBuy€120.00
i
11/8/2018Oddo BhfSet Price TargetBuy€116.00
i
11/7/2018JPMorgan Chase & Co.Set Price TargetBuy€110.00
i
11/6/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
11/6/2018CommerzbankSet Price TargetNeutral€107.00
i
11/2/2018Oddo BhfSet Price TargetBuy€116.00
i
11/2/2018Royal Bank of CanadaSet Price TargetSell€65.00
i
11/1/2018JPMorgan Chase & Co.Reiterated RatingBuy€110.00
i
10/15/2018Royal Bank of CanadaSet Price TargetSell€65.00
i
10/11/2018Oddo BhfSet Price TargetBuy€110.00
i
10/1/2018JPMorgan Chase & Co.Set Price TargetBuy€110.00
i
10/1/2018Royal Bank of CanadaSet Price TargetSell€65.00
i
9/27/2018Independent ResearchSet Price TargetNeutral€105.00
i
9/26/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
9/7/2018Berenberg BankSet Price TargetNeutral€108.00
i
8/22/2018CommerzbankSet Price TargetNeutral€107.00
i
8/14/2018HSBCSet Price TargetSell€56.00
i
8/7/2018Independent ResearchSet Price TargetNeutral€120.00
i
8/6/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€120.00
i
8/3/2018Oddo BhfSet Price TargetNeutral€110.00
i
8/2/2018Berenberg BankSet Price TargetBuy€103.00
i
8/2/2018JPMorgan Chase & Co.Set Price TargetBuy€100.00
i
7/31/2018CommerzbankSet Price TargetBuy€98.00
i
7/30/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€120.00
i
7/27/2018Oddo BhfSet Price TargetBuy€110.00
i
7/20/2018Independent ResearchSet Price TargetNeutral€120.00
i
7/19/2018CommerzbankSet Price TargetBuy€98.00
i
7/19/2018Royal Bank of CanadaSet Price TargetSell€62.00
i
7/19/2018JPMorgan Chase & Co.Set Price TargetBuy€100.00
i
7/19/2018Oddo BhfSet Price TargetBuy€110.00
i
7/6/2018Independent ResearchSet Price TargetNeutral€110.00
i
6/18/2018Oddo BhfSet Price TargetBuy€106.00
i
6/13/2018Royal Bank of CanadaSet Price TargetSell€62.00
i
5/31/2018Royal Bank of CanadaSet Price TargetSell€62.00
i
5/24/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
5/23/2018Berenberg BankSet Price TargetBuy€103.00
i
5/17/2018JPMorgan Chase & Co.Set Price TargetBuy€100.00
i
5/15/2018Berenberg BankSet Price TargetBuy€103.00
i
5/8/2018Independent ResearchSet Price TargetBuy€103.00
i
5/4/2018Oddo BhfSet Price TargetBuy€93.00
i
5/3/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
5/2/2018Royal Bank of CanadaSet Price TargetSell€58.00
i
5/2/2018CommerzbankSet Price TargetBuy€98.00
i
5/1/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€95.00
i
4/18/2018CommerzbankSet Price TargetBuy€98.00
i
4/9/2018Bryan, Garnier & CoSet Price TargetBuy€91.00
i
3/19/2018CommerzbankSet Price TargetBuy€98.00
i
3/14/2018Oddo BhfSet Price TargetBuy€93.00
i
3/14/2018Bryan, Garnier & CoSet Price TargetBuy€91.20
i
3/14/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
3/13/2018Independent ResearchSet Price TargetBuy€97.00
i
3/13/2018Berenberg BankSet Price TargetBuy€85.00
i
3/13/2018Royal Bank of CanadaSet Price TargetSell€57.00
i
3/13/2018JPMorgan Chase & Co.Reiterated RatingBuy€100.00
i
3/12/2018CommerzbankSet Price TargetBuy€98.00
i
3/12/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€94.00
i
3/8/2018The Goldman Sachs GroupSet Price TargetNeutral€86.00
i
2/20/2018Oddo BhfSet Price TargetBuy€90.00
i
2/14/2018Royal Bank of CanadaSet Price TargetSell€57.00
i
1/19/2018HSBCSet Price TargetSell€64.00
i
1/15/2018JPMorgan Chase & Co.Reiterated RatingBuy
i
1/4/2018JPMorgan Chase & Co.Set Price TargetBuy€97.00
i
12/29/2017JPMorgan Chase & Co.Set Price TargetBuy€97.00
i
12/12/2017JPMorgan Chase & Co.Set Price TargetBuy€86.00
i
12/7/2017Berenberg BankSet Price TargetBuy€85.00
i
12/1/2017Independent ResearchSet Price TargetBuy€93.00
i
11/27/2017The Goldman Sachs GroupSet Price TargetNeutral€80.00
i
11/8/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€90.00
i
11/8/2017Oddo BhfSet Price TargetBuy€90.00
i
11/8/2017The Goldman Sachs GroupSet Price TargetNeutral€72.00
i
11/8/2017JPMorgan Chase & Co.Set Price TargetBuy€85.00
i
11/7/2017Berenberg BankSet Price TargetBuy€85.00
i
11/7/2017Independent ResearchSet Price TargetBuy€93.00
i
11/7/2017CommerzbankSet Price TargetBuy€76.00
i
11/2/2017JPMorgan Chase & Co.Reiterated RatingBuy€85.00
i
11/1/2017Berenberg BankSet Price TargetBuy€85.00
i
10/30/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€90.00
i
10/26/2017Oddo BhfSet Price TargetBuy€81.00
i
10/25/2017The Goldman Sachs GroupSet Price TargetNeutral€72.00
i
10/24/2017CommerzbankSet Price TargetBuy€76.00
i
10/19/2017Berenberg BankSet Price TargetBuy€85.00
i
10/6/2017JPMorgan Chase & Co.Set Price TargetBuy€85.00
i
10/4/2017Independent ResearchSet Price TargetBuy€84.00
i
9/28/2017The Goldman Sachs GroupSet Price TargetNeutral€72.00
i
9/27/2017CommerzbankSet Price TargetBuy€76.00
i
9/25/2017Oddo BhfSet Price TargetBuy€81.00
i
9/21/2017CommerzbankSet Price TargetBuy€76.00
i
9/19/2017Berenberg BankSet Price TargetBuy€68.00
i
9/19/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
9/7/2017Oddo BhfSet Price TargetBuy€76.00
i
9/7/2017Independent ResearchSet Price TargetBuy€77.00
i
9/7/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€90.00
i
9/7/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
9/6/2017JPMorgan Chase & Co.Reiterated RatingNeutral
i
9/6/2017CommerzbankSet Price TargetBuy€76.00
i
8/31/2017CommerzbankSet Price TargetBuy€76.00
i
8/16/2017Berenberg BankSet Price TargetBuy€68.00
i
8/7/2017Independent ResearchSet Price TargetBuy€77.00
i
8/7/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€90.00
i
8/4/2017JPMorgan Chase & Co.Set Price TargetNeutral€62.00
i
8/4/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
8/3/2017Berenberg BankSet Price TargetBuy€68.00
i
8/1/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€90.00
i
7/24/2017Independent ResearchSet Price TargetBuy€77.00
i
7/24/2017CommerzbankSet Price TargetBuy€76.00
i
7/24/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
7/17/2017JPMorgan Chase & Co.Reiterated RatingNeutral
i
7/17/2017Independent ResearchSet Price TargetBuy€77.00
i
7/17/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
7/14/2017CommerzbankSet Price TargetBuy€76.00
i
7/14/2017Berenberg BankSet Price TargetBuy€68.00
i
6/6/2017The Goldman Sachs GroupSet Price TargetNeutral€55.00
i
6/6/2017CommerzbankSet Price TargetBuy€76.00
i
5/30/2017CommerzbankSet Price TargetBuy€76.00
i
5/29/2017Independent ResearchSet Price TargetBuy€77.00
i
5/25/2017Berenberg BankSet Price TargetBuy€68.00
i
(Data available from 4/19/2016 forward)
MorphoSys logo
MorphoSys AG, together with its subsidiaries, discovers, develops and commercializes therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. Its lead product candidate is Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B cell lymphoma and chronic lymphocytic leukemia. The company develops Tremfya, an antibody to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and adenomatous polyposis diseases; Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; and MOR106, an antibody for atopic dermatitis. It also develops Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation for the development and commercialization of MorphoSys investigational compound tafasitamab (MOR208); and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany.
Read More

Today's Range

Now: €75.58
€75.48
€77.40

50 Day Range

MA: €78.63
€72.90
€85.96

52 Week Range

Now: €75.58
€71.62
€125.20

Volume

220,199 shs

Average Volume

153,687 shs

Market Capitalization

$2.48 billion

P/E Ratio

25.44

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MorphoSys?

The following Wall Street sell-side analysts have issued reports on MorphoSys in the last year: Barclays PLC, Berenberg Bank, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Independent Research GmbH, JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for MOR.

What is the current price target for MorphoSys?

9 Wall Street analysts have set twelve-month price targets for MorphoSys in the last year. Their average twelve-month price target is €109.78, suggesting a possible upside of 45.2%. Berenberg Bank has the highest price target set, predicting MOR will reach €140.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of €88.00 for MorphoSys in the next year.
View the latest price targets for MOR.

What is the current consensus analyst rating for MorphoSys?

MorphoSys currently has 5 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MOR, but not buy more shares or sell existing shares.
View the latest ratings for MOR.

What other companies compete with MorphoSys?

How do I contact MorphoSys' investor relations team?

MorphoSys' physical mailing address is Semmelweisstr. 7, PLANEGG, 82152, Germany. The company's listed phone number is +49-89-899270. The official website for MorphoSys is www.morphosys.de.